Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2026-01-09 @ 6:19 PM
Study NCT ID:
NCT06533761
Status:
RECRUITING
Last Update Posted:
2025-10-22
First Post:
2024-07-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Sponsor:
Organization: